Review



american 17 type culture collection  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC american 17 type culture collection
    American 17 Type Culture Collection, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 71 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm42810495-70-15-20
    Average 94 stars, based on 71 article reviews
    american 17 type culture collection - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
    Article Snippet: Cell strains included Primary Renal Cortical Cells, ATCC Cat #PCS-400-011, HCA2 foreskin fibroblast cells, Primary Small Airway Epithelial Cells, ATCC Cat #PCS-301-010 (lung), human pooled Preadipocyte from patients (Pread), Mouse embryonic fibroblast extracted from C57BI6 mice (MEF), Primary Coronary Artery Smooth Muscle, and ATCC Cat #PCS-100-021 (Smth Mscl).

    Article Title: Treating cognitive decline and other neurodegenerative conditions by selectively removing senescent cells from neurological tissue
    Article Snippet: Cell strains included Primary Renal Cortical Cells, ATCC Cat # PCS-400-011 (FIG. 20), HCA2 foreskin fibroblast cells (FIG. 21), Primary Small Airway Epithelial Cells, ATCC Cat # PCS-301-010 (lung) (FIG. 22), human pooled Preadipocyte from patients (Pread) (FIG. 23), Mouse embryonic fibroblast extracted from C57Bl6 mice (MEF) (FIG. 24), Primary Coronary Artery Smooth Muscle, ATCC Cat # PCS-100-021 (Smth Mscl) (FIG. 25).

    Article Title: Treating cardiovascular disease by selectively eliminating senescent cells
    Article Snippet: Cell strains included Primary Renal Cortical Cells, ATCC Cat # PCS-400-011 (FIG. 20), HCA2 foreskin fibroblast cells (FIG. 21), Primary Small Airway Epithelial Cells, ATCC Cat # PCS-301-010 (lung) (FIG. 22), human pooled Preadipocyte from patients (Pread) (FIG. 23), Mouse embryonic fibroblast extracted from C571316 mice (MEF) (FIG. 24), Primary Coronary Artery Smooth Muscle, ATCC Cat # PCS-100-021 (Smth Mscl) (FIG. 25).

    Article Title: Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss
    Article Snippet: Cell strains included Primary Renal Cortical Cells, ATCC Cat# PCS-400-011 (FIG. 20), HCA2 foreskin fibroblast cells (FIG. 21), Primary Small Airway Epithelial Cells, ATCC Cat#PCS-301-010 (lung) (FIG. 22), human pooled Preadipocyte from patients (Pread) (FIG. 23), Mouse embryonic fibroblast extracted from C57B16 mice (MEF) (FIG. 24), Primary Coronary Artery Smooth Muscle, ATCC Cat# PCS-100-021 (Smth Mscl) (FIG. 25).

    Article Title: Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase
    Article Snippet: Cell strains included Primary Renal Cortical Cells, ATCC Cat# PCS-400-011 (FIG. 20), HCA2 foreskin fibroblast cells (FIG. 21), Primary Small Airway Epithelial Cells, ATCC Cat# PCS-301-010 (lung) (FIG. 22), human pooled Preadipocyte from patients (Pread) (FIG. 23), Mouse embryonic fibroblast extracted from C571316 mice (MEF) (FIG. 24), Primary Coronary Artery Smooth Muscle, ATCC Cat# PCS-100-021 (Smth Mscl) (FIG. 25).

    Article Title: Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor
    Article Snippet: Cell strains included Primary Renal Cortical Cells, ATCC Cat# PCS-400-011 (FIG. 20), HCA2 foreskin fibroblast cells (FIG. 21), Primary Small Airway Epithelial Cells, ATCC Cat# PCS-301-010 (lung) (FIG. 22), human pooled Preadipocyte from patients (Pread) (FIG. 23), Mouse embryonic fibroblast extracted from C57BI6 mice (MEF) (FIG. 24), Primary Coronary Artery Smooth Muscle, ATCC Cat# PCS-100-021 (Smth Mscl) (FIG. 25).

    In Vitro:

    Article Title: Targeting epidermal growth factor to treat vascular calcification
    Article Snippet: .. Osteogenic Stimulation, In vitro Calcification, and Extracellular Vesicles Isolation Primary human coronary artery vascular smooth muscle cells, (VSMCs, ATCC, PCS-100-021) were cultured using vascular smooth muscle cell media and growth kit (ATCC, PCS-100-042). .. VSMCs (passage 4-6) were harvested using 0.05% trypsin-EDTA solution (Caisson Labs, TRL04) and seeded with a density of 26,320 cells.cm−2 and incubated for 72 hours at 37° C., 5% CO2 with controlled humidity prior to treatment.

    Isolation:

    Article Title: Targeting epidermal growth factor to treat vascular calcification
    Article Snippet: .. Osteogenic Stimulation, In vitro Calcification, and Extracellular Vesicles Isolation Primary human coronary artery vascular smooth muscle cells, (VSMCs, ATCC, PCS-100-021) were cultured using vascular smooth muscle cell media and growth kit (ATCC, PCS-100-042). .. VSMCs (passage 4-6) were harvested using 0.05% trypsin-EDTA solution (Caisson Labs, TRL04) and seeded with a density of 26,320 cells.cm−2 and incubated for 72 hours at 37° C., 5% CO2 with controlled humidity prior to treatment.

    Cell Culture:

    Article Title: Targeting epidermal growth factor to treat vascular calcification
    Article Snippet: .. Osteogenic Stimulation, In vitro Calcification, and Extracellular Vesicles Isolation Primary human coronary artery vascular smooth muscle cells, (VSMCs, ATCC, PCS-100-021) were cultured using vascular smooth muscle cell media and growth kit (ATCC, PCS-100-042). .. VSMCs (passage 4-6) were harvested using 0.05% trypsin-EDTA solution (Caisson Labs, TRL04) and seeded with a density of 26,320 cells.cm−2 and incubated for 72 hours at 37° C., 5% CO2 with controlled humidity prior to treatment.



    Similar Products

    94
    ATCC american 17 type culture collection
    American 17 Type Culture Collection, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm42810495-70-15-20
    Average 94 stars, based on 1 article reviews
    american 17 type culture collection - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC coronary artery smooth muscle cells
    Coronary Artery Smooth Muscle Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm42276139-38-6-12
    Average 94 stars, based on 1 article reviews
    coronary artery smooth muscle cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC atcc pcs 100 021 lot n◦ 804020 human aortic smooth muscle cells
    Atcc Pcs 100 021 Lot N◦ 804020 Human Aortic Smooth Muscle Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/10__1016_slash_j__isci__2026__115886-282-2-2
    Average 94 stars, based on 1 article reviews
    atcc pcs 100 021 lot n◦ 804020 human aortic smooth muscle cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC human coronary artery smooth muscle cells hcasmcs
    Human Coronary Artery Smooth Muscle Cells Hcasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm41526342-264-13-20
    Average 94 stars, based on 1 article reviews
    human coronary artery smooth muscle cells hcasmcs - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC primary human coronary artery smooth muscle cells
    The 9p21.3 <t>coronary</t> <t>artery</t> disease (CAD) locus maps to an enhancer dense region in CAD-relevant cell types. (A) Manhattan plot showing Phenome-wide association (PheWAS) of 9p21.3 locus (tagged by rs4977574) to multiple disease traits in FinnGen data freeze 13 (DF13). Each triangle represents a phenotype association at 9p21.3 locus and different triangle colors represent various classification of phenotypes. Direction of the triangle indicates increased directionality of association. Increased risk is indicated by an upward triangle and reduced risk is indicated by a downward facing triangle. (B) Schematic depicting an extensive vascular cell wall profiling at baseline and in response to CAD-relevant stimulatory condition. (C) Chromatin state and epigenetic landscape of 9p21.3 CAD haplotype spanning ∼ 50-kb DNA sequence within the 3’ region of long non-coding RNA CDKN2B-AS1 ( ANRIL ). Also depicted are all 50 CAD associated SNPs (r 2 > 0.8), tagged by rs4977573 and credible set variants from FinnGen and UKBB finemapping efforts. (D-E) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) vascular fibroblast and <t>smooth</t> <t>muscle</t> <t>cells.</t> Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (F-G) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in vascular fibroblast and smooth muscle cells. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3.
    Primary Human Coronary Artery Smooth Muscle Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/bio_rxiv__2025__11__18__689066-268-10-17
    Average 94 stars, based on 1 article reviews
    primary human coronary artery smooth muscle cells - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC hcasmcs
    The 9p21.3 <t>coronary</t> <t>artery</t> disease (CAD) locus maps to an enhancer dense region in CAD-relevant cell types. (A) Manhattan plot showing Phenome-wide association (PheWAS) of 9p21.3 locus (tagged by rs4977574) to multiple disease traits in FinnGen data freeze 13 (DF13). Each triangle represents a phenotype association at 9p21.3 locus and different triangle colors represent various classification of phenotypes. Direction of the triangle indicates increased directionality of association. Increased risk is indicated by an upward triangle and reduced risk is indicated by a downward facing triangle. (B) Schematic depicting an extensive vascular cell wall profiling at baseline and in response to CAD-relevant stimulatory condition. (C) Chromatin state and epigenetic landscape of 9p21.3 CAD haplotype spanning ∼ 50-kb DNA sequence within the 3’ region of long non-coding RNA CDKN2B-AS1 ( ANRIL ). Also depicted are all 50 CAD associated SNPs (r 2 > 0.8), tagged by rs4977573 and credible set variants from FinnGen and UKBB finemapping efforts. (D-E) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) vascular fibroblast and <t>smooth</t> <t>muscle</t> <t>cells.</t> Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (F-G) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in vascular fibroblast and smooth muscle cells. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3.
    Hcasmcs, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm41011253-213-1-2
    Average 94 stars, based on 1 article reviews
    hcasmcs - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    ATCC human coronary artery smooth muscle cells hcasmc
    The 9p21.3 <t>coronary</t> <t>artery</t> disease (CAD) locus maps to an enhancer dense region in CAD-relevant cell types. (A) Manhattan plot showing Phenome-wide association (PheWAS) of 9p21.3 locus (tagged by rs4977574) to multiple disease traits in FinnGen data freeze 13 (DF13). Each triangle represents a phenotype association at 9p21.3 locus and different triangle colors represent various classification of phenotypes. Direction of the triangle indicates increased directionality of association. Increased risk is indicated by an upward triangle and reduced risk is indicated by a downward facing triangle. (B) Schematic depicting an extensive vascular cell wall profiling at baseline and in response to CAD-relevant stimulatory condition. (C) Chromatin state and epigenetic landscape of 9p21.3 CAD haplotype spanning ∼ 50-kb DNA sequence within the 3’ region of long non-coding RNA CDKN2B-AS1 ( ANRIL ). Also depicted are all 50 CAD associated SNPs (r 2 > 0.8), tagged by rs4977573 and credible set variants from FinnGen and UKBB finemapping efforts. (D-E) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) vascular fibroblast and <t>smooth</t> <t>muscle</t> <t>cells.</t> Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (F-G) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in vascular fibroblast and smooth muscle cells. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3.
    Human Coronary Artery Smooth Muscle Cells Hcasmc, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery+Smooth+Muscle+Cells%3B+Normal%2C+Human/pmc12347766-180-30-40
    Average 94 stars, based on 1 article reviews
    human coronary artery smooth muscle cells hcasmc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    ATCC primary human coronary artery smooth muscle cells smcs
    The 9p21.3 <t>coronary</t> <t>artery</t> disease (CAD) locus maps to an enhancer dense region in CAD-relevant cell types. (A) Manhattan plot showing Phenome-wide association (PheWAS) of 9p21.3 locus (tagged by rs4977574) to multiple disease traits in FinnGen data freeze 13 (DF13). Each triangle represents a phenotype association at 9p21.3 locus and different triangle colors represent various classification of phenotypes. Direction of the triangle indicates increased directionality of association. Increased risk is indicated by an upward triangle and reduced risk is indicated by a downward facing triangle. (B) Schematic depicting an extensive vascular cell wall profiling at baseline and in response to CAD-relevant stimulatory condition. (C) Chromatin state and epigenetic landscape of 9p21.3 CAD haplotype spanning ∼ 50-kb DNA sequence within the 3’ region of long non-coding RNA CDKN2B-AS1 ( ANRIL ). Also depicted are all 50 CAD associated SNPs (r 2 > 0.8), tagged by rs4977573 and credible set variants from FinnGen and UKBB finemapping efforts. (D-E) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) vascular fibroblast and <t>smooth</t> <t>muscle</t> <t>cells.</t> Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (F-G) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in vascular fibroblast and smooth muscle cells. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3.
    Primary Human Coronary Artery Smooth Muscle Cells Smcs, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcs+100+021/Primary+Coronary+Artery%3B+Smooth+Muscle+Cells%3B+Normal%2C+Human/pm40481235-30-8-20
    Average 93 stars, based on 1 article reviews
    primary human coronary artery smooth muscle cells smcs - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    Image Search Results


    The 9p21.3 coronary artery disease (CAD) locus maps to an enhancer dense region in CAD-relevant cell types. (A) Manhattan plot showing Phenome-wide association (PheWAS) of 9p21.3 locus (tagged by rs4977574) to multiple disease traits in FinnGen data freeze 13 (DF13). Each triangle represents a phenotype association at 9p21.3 locus and different triangle colors represent various classification of phenotypes. Direction of the triangle indicates increased directionality of association. Increased risk is indicated by an upward triangle and reduced risk is indicated by a downward facing triangle. (B) Schematic depicting an extensive vascular cell wall profiling at baseline and in response to CAD-relevant stimulatory condition. (C) Chromatin state and epigenetic landscape of 9p21.3 CAD haplotype spanning ∼ 50-kb DNA sequence within the 3’ region of long non-coding RNA CDKN2B-AS1 ( ANRIL ). Also depicted are all 50 CAD associated SNPs (r 2 > 0.8), tagged by rs4977573 and credible set variants from FinnGen and UKBB finemapping efforts. (D-E) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) vascular fibroblast and smooth muscle cells. Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (F-G) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in vascular fibroblast and smooth muscle cells. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3.

    Journal: bioRxiv

    Article Title: The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP

    doi: 10.1101/2025.11.18.689066

    Figure Lengend Snippet: The 9p21.3 coronary artery disease (CAD) locus maps to an enhancer dense region in CAD-relevant cell types. (A) Manhattan plot showing Phenome-wide association (PheWAS) of 9p21.3 locus (tagged by rs4977574) to multiple disease traits in FinnGen data freeze 13 (DF13). Each triangle represents a phenotype association at 9p21.3 locus and different triangle colors represent various classification of phenotypes. Direction of the triangle indicates increased directionality of association. Increased risk is indicated by an upward triangle and reduced risk is indicated by a downward facing triangle. (B) Schematic depicting an extensive vascular cell wall profiling at baseline and in response to CAD-relevant stimulatory condition. (C) Chromatin state and epigenetic landscape of 9p21.3 CAD haplotype spanning ∼ 50-kb DNA sequence within the 3’ region of long non-coding RNA CDKN2B-AS1 ( ANRIL ). Also depicted are all 50 CAD associated SNPs (r 2 > 0.8), tagged by rs4977573 and credible set variants from FinnGen and UKBB finemapping efforts. (D-E) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) vascular fibroblast and smooth muscle cells. Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (F-G) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in vascular fibroblast and smooth muscle cells. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3.

    Article Snippet: We utilized human vascular fibroblasts (Cell Systems, ACBRI 5118) and primary human coronary artery smooth muscle cells (ATCC; PCS-100-021).

    Techniques: Sequencing

    Characterization of 9p21.3 enhancers and identification of cell-types mediating risk for CAD (A-D) Plots showing super enhancers (blue), enhancers (red), and enhancers within 9p21.3 haplotype (green). (E-G) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) atrial derived fibroblast, coronary artery derived endothelial cells, and adipose derived pericytes. Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (H-I) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in endothelial cells and pericytes. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3. (J) T-statistic versus absolute t-statistic (y-axis) for gene expression across five primary human vascular cell types under basal conditions. Differentially expressed genes, representing the top 10% by absolute t-statistic, are highlighted in red; all other genes are in blue. The dashed line indicates a high absolute t-statistic threshold.

    Journal: bioRxiv

    Article Title: The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP

    doi: 10.1101/2025.11.18.689066

    Figure Lengend Snippet: Characterization of 9p21.3 enhancers and identification of cell-types mediating risk for CAD (A-D) Plots showing super enhancers (blue), enhancers (red), and enhancers within 9p21.3 haplotype (green). (E-G) Dot plots showing enrichment for CAD heritability at baseline and in response to CAD-relevant stimulatory conditions, including Inflammatory (IL-1α and IL-6 & TNF-α) atrial derived fibroblast, coronary artery derived endothelial cells, and adipose derived pericytes. Solid dark lines around each dot represent significance at a threshold of -log 10 (adjusted P-value) ≥ 3.35. (H-I) Dot plots showing the impact of CAD-relevant stimulatory conditions on enhancer activities (proxy of H3K27ac) at 9p21.3 locus in endothelial cells and pericytes. Fold changes are indicated as Red (increased fold change) or Blue (Reduced fold change) and solid dark lines around each dot represent significance at a threshold of -log 10 (FDR) ≥ 1.3. (J) T-statistic versus absolute t-statistic (y-axis) for gene expression across five primary human vascular cell types under basal conditions. Differentially expressed genes, representing the top 10% by absolute t-statistic, are highlighted in red; all other genes are in blue. The dashed line indicates a high absolute t-statistic threshold.

    Article Snippet: We utilized human vascular fibroblasts (Cell Systems, ACBRI 5118) and primary human coronary artery smooth muscle cells (ATCC; PCS-100-021).

    Techniques: Derivative Assay, Gene Expression

    The 9p21.3 locus contains multiple functional vascular cell enhancers regulating cis-expressing genes. (A) Contact matrix (at 5000 bp resolution) from Micro-C 1 analysis of the H1 human embryonic stem cell (h1-ESC) spanning 1 Mb around 9p21.3 CAD haplotype (indicated as a blue rectangle). (B) Schematic showing experimental workflow to identify all functional non-coding 9p21.3 elements by CRISPR interference (CRISPRi) paired with Multiplex Analysis of Cells (MAC-seq) sequencing readout collectively referred to as CRISPRi-MAC-seq. (C) Donut plot showing the proportion of control, TSS-targeting, enhancer-targeting, and SNP-targeting guides (n=417 total guides) in our densely-tiled 9p21.3 library. (C) Box plots showing TSS repression efficiency via assessing normalized MTAP expression in vascular fibroblasts and smooth muscle cells treated with lentivirus containing transcriptional start site (TSS) guides for MTAP (n=4) compared to non-targeting control (n=13). Significance was determined using a two-tailed t-test, with a significance threshold of P-value<0.05. (E-F) Plot shows a sliding window approach that aggregates sgRNA transcriptional effects across a subset of the 9p21.3 annotated enhancers, including E4, E5, E8 and E9 in vascular fibroblast and smooth muscle cells. To assign significance to observed data relative to the permutation background, a permutation z-score was calculated. A significance level of z-score<-1.96 was used to identify significantly repressed regions – illustrated as red points on the sliding window plots.

    Journal: bioRxiv

    Article Title: The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP

    doi: 10.1101/2025.11.18.689066

    Figure Lengend Snippet: The 9p21.3 locus contains multiple functional vascular cell enhancers regulating cis-expressing genes. (A) Contact matrix (at 5000 bp resolution) from Micro-C 1 analysis of the H1 human embryonic stem cell (h1-ESC) spanning 1 Mb around 9p21.3 CAD haplotype (indicated as a blue rectangle). (B) Schematic showing experimental workflow to identify all functional non-coding 9p21.3 elements by CRISPR interference (CRISPRi) paired with Multiplex Analysis of Cells (MAC-seq) sequencing readout collectively referred to as CRISPRi-MAC-seq. (C) Donut plot showing the proportion of control, TSS-targeting, enhancer-targeting, and SNP-targeting guides (n=417 total guides) in our densely-tiled 9p21.3 library. (C) Box plots showing TSS repression efficiency via assessing normalized MTAP expression in vascular fibroblasts and smooth muscle cells treated with lentivirus containing transcriptional start site (TSS) guides for MTAP (n=4) compared to non-targeting control (n=13). Significance was determined using a two-tailed t-test, with a significance threshold of P-value<0.05. (E-F) Plot shows a sliding window approach that aggregates sgRNA transcriptional effects across a subset of the 9p21.3 annotated enhancers, including E4, E5, E8 and E9 in vascular fibroblast and smooth muscle cells. To assign significance to observed data relative to the permutation background, a permutation z-score was calculated. A significance level of z-score<-1.96 was used to identify significantly repressed regions – illustrated as red points on the sliding window plots.

    Article Snippet: We utilized human vascular fibroblasts (Cell Systems, ACBRI 5118) and primary human coronary artery smooth muscle cells (ATCC; PCS-100-021).

    Techniques: Functional Assay, Expressing, CRISPR, Multiplex Assay, Sequencing, Control, Two Tailed Test

    Convergent genomics evidence points to MTAP as the primary 9p21.3 CAD effector gene in vascular fibroblast and smooth muscle cells. (A) Density plot of Gnocchi scores across the genome. Windows overlapping coding regions (red color) compared to windows overlapping 9p21.3 non-coding regions (blue color). (B) Distribution of CAD/T2D variants in constraint regions spanning ∼120-kb region on the P-arm of chromosome 9. Overlaid on this plot is enhancer annotation for 9p21.3 locus along with constraint blocks and constraint variants flanking or overlapping enhancer region. (C) Dot plots showing fine-mapped variants associated with a combined trait for coronary revascularization, including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (ANGIO) using data from large-scale population efforts from FinnGen and UKBB. Credible set variants are shaded grey and have the highest magnitude of association to CAD. (D-E) Using a MAGMA gene prioritization approach, we identified CAD-specific genes by calculating genome-wide ZSTAT scores for genes in comparison to a GWAS. Genes with ZSTAT scores exceeding the 0.95 percentile were considered significantly related to the GWAS trait. (D) First, we prioritized 9p21.3 genes against a CAD GWAS. The results indicated that MTAP, CDKN2A, and CDKN2B surpassed the significance cutoff. (E) To assess disease specificity, we then compared these results against a T2D GWAS. This analysis highlighted that MTAP’s association with CAD is disease-specific, as it did not meet the significance cutoff for T2D. (F) Converging evidence for CAD effector gene prioritization. The matrix denotes evidence to provide support (colored blue) for CAD driver genes across different modalities. Top scoring genes have the highest count across all evidence.

    Journal: bioRxiv

    Article Title: The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP

    doi: 10.1101/2025.11.18.689066

    Figure Lengend Snippet: Convergent genomics evidence points to MTAP as the primary 9p21.3 CAD effector gene in vascular fibroblast and smooth muscle cells. (A) Density plot of Gnocchi scores across the genome. Windows overlapping coding regions (red color) compared to windows overlapping 9p21.3 non-coding regions (blue color). (B) Distribution of CAD/T2D variants in constraint regions spanning ∼120-kb region on the P-arm of chromosome 9. Overlaid on this plot is enhancer annotation for 9p21.3 locus along with constraint blocks and constraint variants flanking or overlapping enhancer region. (C) Dot plots showing fine-mapped variants associated with a combined trait for coronary revascularization, including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (ANGIO) using data from large-scale population efforts from FinnGen and UKBB. Credible set variants are shaded grey and have the highest magnitude of association to CAD. (D-E) Using a MAGMA gene prioritization approach, we identified CAD-specific genes by calculating genome-wide ZSTAT scores for genes in comparison to a GWAS. Genes with ZSTAT scores exceeding the 0.95 percentile were considered significantly related to the GWAS trait. (D) First, we prioritized 9p21.3 genes against a CAD GWAS. The results indicated that MTAP, CDKN2A, and CDKN2B surpassed the significance cutoff. (E) To assess disease specificity, we then compared these results against a T2D GWAS. This analysis highlighted that MTAP’s association with CAD is disease-specific, as it did not meet the significance cutoff for T2D. (F) Converging evidence for CAD effector gene prioritization. The matrix denotes evidence to provide support (colored blue) for CAD driver genes across different modalities. Top scoring genes have the highest count across all evidence.

    Article Snippet: We utilized human vascular fibroblasts (Cell Systems, ACBRI 5118) and primary human coronary artery smooth muscle cells (ATCC; PCS-100-021).

    Techniques: Genome Wide, Comparison

    (A) Uniform manifold approximation and projection (UMAP) of scMultiome (scATAC-seq + scRNA-seq) data from Human left anterior descending (LAD) coronary artery, with cells colored by cell types (B) Density plot showing cell type specific markers for vascular smooth muscle cell ( ACTA2 , MYH11 , MYL9 , and TAGLN ) and vascular fibroblasts ( LUM , DCN , COL3A1 , and LAMA2 ). (C) Bar plot showing significant 9p21.3 tile-to-gene pair counts of 9p21.3 cis-expressing genes ( MTAP , DMRTA1 , and CDKN2B-AS1 ) stratified by genotype at rs1537371 in vascular fibroblasts and smooth muscle cells (D) Genomic track shows accessibility of 9p21.3 locus at rs1537371 SNP in vascular fibroblast. (E) Allelic dependent pseudobulk mRNA expression of MTAP in vascular fibroblast (F) Genomic track shows accessibility of 9p21.3 locus at rs1537371 SNP in vascular smooth muscle. (G) Allelic dependent pseudobulk expression of MTAP in vascular smooth muscle

    Journal: bioRxiv

    Article Title: The 9p21.3 Coronary Artery Disease Risk Locus Modulates Vascular Cell-State Transitions via Enhancer-Driven Regulation of MTAP

    doi: 10.1101/2025.11.18.689066

    Figure Lengend Snippet: (A) Uniform manifold approximation and projection (UMAP) of scMultiome (scATAC-seq + scRNA-seq) data from Human left anterior descending (LAD) coronary artery, with cells colored by cell types (B) Density plot showing cell type specific markers for vascular smooth muscle cell ( ACTA2 , MYH11 , MYL9 , and TAGLN ) and vascular fibroblasts ( LUM , DCN , COL3A1 , and LAMA2 ). (C) Bar plot showing significant 9p21.3 tile-to-gene pair counts of 9p21.3 cis-expressing genes ( MTAP , DMRTA1 , and CDKN2B-AS1 ) stratified by genotype at rs1537371 in vascular fibroblasts and smooth muscle cells (D) Genomic track shows accessibility of 9p21.3 locus at rs1537371 SNP in vascular fibroblast. (E) Allelic dependent pseudobulk mRNA expression of MTAP in vascular fibroblast (F) Genomic track shows accessibility of 9p21.3 locus at rs1537371 SNP in vascular smooth muscle. (G) Allelic dependent pseudobulk expression of MTAP in vascular smooth muscle

    Article Snippet: We utilized human vascular fibroblasts (Cell Systems, ACBRI 5118) and primary human coronary artery smooth muscle cells (ATCC; PCS-100-021).

    Techniques: Expressing